Jennifer M Taber1, Lisa G Aspinwall2, Karen A Heichman3, Anita Y Kinney4. 1. Department of Psychology, University of Utah, Salt Lake City, UT, USA. 2. Department of Psychology, University of Utah, Salt Lake City, UT, USA. lisa.aspinwall@utah.edu. 3. VP Oncology Technology Development, ARUP Laboratories, Inc.; Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT, USA. 4. Department of Internal Medicine, University of New Mexico, USA; Cancer Control and Population Sciences, University of New Mexico Cancer Center, Albuquerque, NM, USA.
Abstract
OBJECTIVES: To examine attitudes of a diverse community-based sample toward SEPT9, a simple, cost-effective colorectal cancer (CRC) blood test. METHODS: One-hundred participants eligible for CRC screening (Mage =58.3; 44% unscreened; 38% white, 31% Hispanic, 31% black) completed cross-sectional surveys of their screening preferences following group discussions of colonoscopy, sigmoidoscopy, FOBT, and SEPT9. RESULTS: Overall, 91% ranked SEPT9 first or second. Controlling for sociodemographic factors, unscreened Whites strongly preferred SEPT9, listing multiple advantages, whereas unscreened Blacks preferred colonoscopy. Only 19% of the sample listed negative aspects. CONCLUSION: Blood-based screening for CRC was widely favored. Future research on medical decision-making should examine the basis for racial/ethnic differences in biomarker screening preferences.
OBJECTIVES: To examine attitudes of a diverse community-based sample toward SEPT9, a simple, cost-effective colorectal cancer (CRC) blood test. METHODS: One-hundred participants eligible for CRC screening (Mage =58.3; 44% unscreened; 38% white, 31% Hispanic, 31% black) completed cross-sectional surveys of their screening preferences following group discussions of colonoscopy, sigmoidoscopy, FOBT, and SEPT9. RESULTS: Overall, 91% ranked SEPT9 first or second. Controlling for sociodemographic factors, unscreened Whites strongly preferred SEPT9, listing multiple advantages, whereas unscreened Blacks preferred colonoscopy. Only 19% of the sample listed negative aspects. CONCLUSION: Blood-based screening for CRC was widely favored. Future research on medical decision-making should examine the basis for racial/ethnic differences in biomarker screening preferences.
Authors: Sumedha V Chablani; Noah Cohen; Drusilla White; Steven H Itzkowitz; Katherine DuHamel; Lina Jandorf Journal: J Immigr Minor Health Date: 2017-10
Authors: David A Johnson; Robert L Barclay; Klaus Mergener; Gunter Weiss; Thomas König; Jürgen Beck; Nicholas T Potter Journal: PLoS One Date: 2014-06-05 Impact factor: 3.240
Authors: Anastasia A Ponomaryova; Elena Y Rykova; Polina A Gervas; Nadezhda V Cherdyntseva; Ilgar Z Mamedov; Tatyana L Azhikina Journal: Cells Date: 2020-09-02 Impact factor: 6.600
Authors: Louise Rasmussen; Michael Wilhelmsen; Ib Jarle Christensen; Jens Andersen; Lars Nannestad Jørgensen; Morten Rasmussen; Jakob W Hendel; Mogens R Madsen; Jesper Vilandt; Thore Hillig; Michael Klærke; Anna-Marie Bloch Münster; Lars M Andersen; Berit Andersen; Nete Hornung; Erland J Erlandsen; Ali Khalid; Hans Jørgen Nielsen Journal: JMIR Res Protoc Date: 2016-09-13